BAGSVAERD, Denmark (AP) — BAGSVAERD, Denmark (AP) — Novo Nordisk A/S (NVO) on Wednesday reported second-quarter profit of $4.03 billion. On a per-share basis, the Bagsvaerd, Denmark-based ...

Novo Nordisk has abandoned another GLP-1/GIP co-agonist and CB1 receptor as part of a significant pipeline clearout that coincides with disappointing obesity sales and a leadership shake-up.

Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit Wednesday, but rising competition is weighing on sales of its diabetes and obesity treatments Ozempic and ...

Novo Nordisk posted a sharp rise in second-quarter net profit, but rising competition is weighing on sales of its diabetes and obesity treatments Ozempic and Wegovy in the United States.

PLAINSBORO, N.J., Aug. 5, 2025 /PRNewswire/ -- Novo Nordisk today announced the filing of 14 new lawsuits to safeguard patients from unsafe and unapproved compounded drugs claiming to contain ...

Novo Nordisk (NYSE: NVO) has presented investors with a flurry of new information to digest. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best ...

Novo Nordisk (NYSE: NVO) made several huge announcements that investors will not want to miss. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best ...

For more information, submit a form at Novo Nordisk A/S Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030.